Assessment of the Severity and the Remission Criteria in Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE) is an immune-mediated disease that manifests with dysphagia and is characterized by the predominantly eosinophilic infiltration of the esophageal mucosa. Several instruments have been developed to assess the symptoms of EoE: the Daily Symptom Questionnaire (DSQ), EoE Activity Index (EEsAI), Pediatric EoE Symptom Severity (PEESSv2), etc. The use of the EREFS is a gold standard for endoscopic diagnosis. The EoE histologic scoring system (EoEHSS) was elaborated for the assessment of histological features in EoE. However, the remission criteria are not clearly defined and vary greatly in different studies. Gastroenterologists establish the severity of EoE mainly based on endoscopic findings. At the same time, EoE requires a multidisciplinary approach. The recently developed Index of Severity of Eosinophilic Esophagitis (I-SEE) that is built on symptoms, endoscopic findings, and histological features is promising.

[1]  G. Mulinacci,et al.  Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms , 2023, Cells.

[2]  E. Dellon,et al.  Medical treatment of eosinophilic esophagitis , 2023, The Cochrane database of systematic reviews.

[3]  J. Woosley,et al.  Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial , 2023, Gut.

[4]  M. Buras,et al.  Food-Specific IgG4 Is Elevated Throughout the Upper Gastrointestinal Tract in Eosinophilic Esophagitis , 2023, Digestive Diseases and Sciences.

[5]  E. Savarino,et al.  Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  A. Bredenoord,et al.  A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. , 2022, Gastroenterology.

[7]  A. Cossarizza,et al.  Effects of Energy Drink Acute Assumption in Gastrointestinal Tract of Rats , 2022, Nutrients.

[8]  M. Vieth,et al.  Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme , 2022, United European gastroenterology journal.

[9]  G. Canonica,et al.  Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets , 2022, Frontiers in Physiology.

[10]  A. Lucendo,et al.  Evidence-based treatments for eosinophilic esophagitis: insights for the clinician , 2022, Therapeutic advances in gastroenterology.

[11]  Lisa J. Martin,et al.  Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis , 2021, The American journal of gastroenterology.

[12]  G. Falk,et al.  Eosinophilic Esophagitis: A Review. , 2021, JAMA.

[13]  P. Czapiewski,et al.  Eosinophilic esophagitis: Comparison of clinical, endoscopic and histological scoring systems , 2021, Zeitschrift für Gastroenterologie.

[14]  A. L. Krarup,et al.  Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate , 2021, United European gastroenterology journal.

[15]  E. Dellon,et al.  Long-Term Treatment of Eosinophilic Esophagitis with Budesonide Oral Suspension. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  Lisa J. Martin,et al.  Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults with Eosinophilic Esophagitis. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  E. Dellon,et al.  Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  C. Wennerås,et al.  Patient-Reported Dysphagia in Adults with Eosinophilic Esophagitis: Translation and Validation of the Swedish Eosinophilic Esophagitis Activity Index , 2021, Dysphagia.

[19]  E. Dellon,et al.  Factors Associated With Adequate Lamina Propria Sampling and Presence of Lamina Propria Fibrosis in Children with Eosinophilic Esophagitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  H. Nakagawa,et al.  Persistent Basal Cell Hyperplasia is Associated with Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  Y. Falck‐Ytter,et al.  Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. , 2020, Gastroenterology.

[22]  A. Schoepfer,et al.  Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[23]  Lisa J. Martin,et al.  Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms. , 2020, Journal of pediatric gastroenterology and nutrition.

[24]  E. Dellon,et al.  Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis. , 2020, The American journal of gastroenterology.

[25]  I. Hirano,et al.  Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. , 2019, Gastroenterology.

[26]  E. Dellon,et al.  EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS. , 2019, The Journal of allergy and clinical immunology.

[27]  G. Yancopoulos,et al.  Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. , 2019, Gastroenterology.

[28]  E. Dellon,et al.  A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  Jessica J. Lee,et al.  Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration. , 2019, Gastroenterology.

[30]  Christopher F. Martin,et al.  Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. , 2019, Gastroenterology.

[31]  P. Capucilli,et al.  Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications , 2019, Clinical Reviews in Allergy & Immunology.

[32]  E. Dellon,et al.  Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[33]  L. Mikhaleva,et al.  Epidemiology, etiology and pathogenesis of eosinophilic esophagitis. The latest data , 2019, Dokazatel'naya gastroenterologiya.

[34]  A. Schoepfer,et al.  Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5‐Year Follow‐up Period In Adult Patients , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  G. Opiteck,et al.  RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. , 2019, Gastroenterology.

[36]  E. Dellon,et al.  Eosinophilic Esophagitis. , 2019, The Medical clinics of North America.

[37]  Nicoleta C. Arva,et al.  Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. , 2018, Gastroenterology.

[38]  Mark J. Ramos,et al.  Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March. , 2018, The journal of allergy and clinical immunology. In practice.

[39]  R. Eke,et al.  Systematic review of histological remission criteria in eosinophilic esophagitis , 2018, JGH open : an open access journal of gastroenterology and hepatology.

[40]  A. Bredenoord,et al.  The Natural Course of Eosinophilic Esophagitis and Long‐Term Consequences of Undiagnosed Disease in a Large Cohort , 2018, The American Journal of Gastroenterology.

[41]  I. Hirano,et al.  Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  J. Woosley,et al.  Optimal Histologic Cutpoints for Treatment Response in Patients With Eosinophilic Esophagitis: Analysis of Data From a Prospective Cohort Study , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  E. Dellon,et al.  Esophageal dilation with either bougie or balloon technique as a treatment for eosinophilic esophagitis: a systematic review and meta-analysis. , 2017, Gastrointestinal endoscopy.

[44]  S. Hudgens,et al.  Psychometric validation of the Dysphagia Symptom Questionnaire in patients with eosinophilic esophagitis treated with budesonide oral suspension , 2017, Journal of Patient-Reported Outcomes.

[45]  E. Dellon,et al.  Epidemiology and Natural History of Eosinophilic Esophagitis. , 2017, Gastroenterology.

[46]  E. Dellon,et al.  White Paper AGA: Drug Development for Eosinophilic Esophagitis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  A. Lucendo,et al.  Systematic review with meta‐analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis , 2017, Alimentary pharmacology & therapeutics.

[48]  E. Dellon,et al.  A visual analogue scale and a Likert scale are simple and responsive tools for assessing dysphagia in eosinophilic oesophagitis , 2017, Alimentary pharmacology & therapeutics.

[49]  A. Lucendo,et al.  Association between atopic manifestations and eosinophilic esophagitis: A systematic review and meta-analysis. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[50]  E. Dellon,et al.  Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. , 2017, Gastroenterology.

[51]  A. Bredenoord,et al.  Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults , 2017, United European gastroenterology journal.

[52]  J. Molina-Infante,et al.  The Endoscopic Reference Score shows modest accuracy to predict either clinical or histological activity in adult patients with eosinophilic oesophagitis , 2017, Alimentary pharmacology & therapeutics.

[53]  M. Hanna,et al.  Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis , 2016, The American Journal of Gastroenterology.

[54]  Jason Y. Park,et al.  JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE , 2016, PloS one.

[55]  A. Bredenoord,et al.  The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[56]  J. Pandolfino,et al.  Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis , 2016, Endoscopy.

[57]  M. Zwahlen,et al.  Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis. , 2016, Gastroenterology.

[58]  Lisa J. Martin,et al.  Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[59]  J. Wo,et al.  Most children with eosinophilic esophagitis have a favorable outcome as young adults. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[60]  J. Woosley,et al.  Evaluation of Histologic Cutpoints for Treatment Response in Eosinophilic Esophagitis. , 2015, Journal of gastroenterology and hepatology research.

[61]  A. Cianferoni,et al.  Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[62]  K. Avis,et al.  Topical Review: Eosinophilic Esophagitis in Children: Implications for Health-Related Quality of Life and Potential Avenues for Future Research. , 2015, Journal of pediatric psychology.

[63]  Lisa J. Martin,et al.  Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. , 2015, The Journal of allergy and clinical immunology.

[64]  M. Vieth,et al.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis , 2015, Gut.

[65]  W. D. de Jonge,et al.  Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[66]  A. Bredenoord,et al.  Evaluating the Endoscopic Reference Score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability , 2014, Endoscopy.

[67]  A. Schoepfer,et al.  Swallowed topical corticosteroids reduce the risk for long‐lasting bolus impactions in eosinophilic esophagitis , 2014, Allergy.

[68]  J. Woosley,et al.  Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy , 2014, Modern Pathology.

[69]  J. Woosley,et al.  A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. , 2014, Gastrointestinal endoscopy.

[70]  A. Schoepfer,et al.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. , 2013, Gastroenterology.

[71]  E. Dellon,et al.  Development and field testing of a novel patient‐reported outcome measure of dysphagia in patients with eosinophilic esophagitis , 2013, Alimentary pharmacology & therapeutics.

[72]  J. Pandolfino,et al.  Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[73]  E. Dellon,et al.  ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE) , 2013, The American Journal of Gastroenterology.

[74]  N. Shaheen,et al.  The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  I. Hirano,et al.  Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. , 2012, World journal of gastroenterology.

[76]  J. Woosley,et al.  Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. , 2012, Gastroenterology.

[77]  T. Smyrk,et al.  Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[78]  I. Hirano,et al.  Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. , 2012, Gastroenterology.

[79]  M. Heckman,et al.  Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system , 2012, Gut.

[80]  S. Spechler,et al.  Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD , 2012, Gut.

[81]  A. Schoepfer,et al.  Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. , 2010, Gastroenterology.

[82]  A. Zinsmeister,et al.  The Mayo Dysphagia Questionnaire-30: Documentation of Reliability and Validity of a Tool for Interventional Trials in Adults with Esophageal Disease , 2010, Dysphagia.

[83]  S. Aceves,et al.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. , 2010, Gastroenterology.

[84]  S. Aceves,et al.  A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation. , 2009, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[85]  M. Collins,et al.  Dissociation Between Symptoms and Histological Severity in Pediatric Eosinophilic Esophagitis , 2009, Journal of pediatric gastroenterology and nutrition.

[86]  N. Talley,et al.  Validation of the Mayo Dysphagia Questionnaire. , 2007, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[87]  R. Noel,et al.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. , 2006, Gastroenterology.

[88]  K. Badizadegan,et al.  Association of eosinophilic inflammation with esophageal food impaction in adults. , 2005, Gastrointestinal endoscopy.

[89]  G. Kudryavtsev,et al.  Clinical and morphological diagnosis of eosinophilic esophagitis , 2023, CLINICAL AND EXPERIMENTAL MORPHOLOGY.

[90]  Nicholas J Shaheen,et al.  Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[91]  D. Broide,et al.  Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. , 2016, The Journal of allergy and clinical immunology.

[92]  J. Vitanza,et al.  Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[93]  E. Dellon,et al.  Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. , 2015, The Journal of allergy and clinical immunology.

[94]  Ikuo Hirano,et al.  Mechanical properties of the esophagus in eosinophilic esophagitis. , 2011, Gastroenterology.